Compounds > propyl pyrazinoate
Page last updated: 2024-08-25

propyl pyrazinoate and 5-chloropyrazinamide

propyl pyrazinoate has been researched along with 5-chloropyrazinamide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, M; Jacobs, WR; Vilchèze, C; Welch, JT; Zimhony, O1
Chung, WJ; Jacobs, WR; Ngo, SC; Sayahi, H; Welch, JT; Zimhony, O1
Baughn, AD; Dillon, NA; Peterson, ND; Rosen, BC1

Other Studies

3 other study(ies) available for propyl pyrazinoate and 5-chloropyrazinamide

ArticleYear
Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Bacterial Proteins; Fatty Acid Synthases; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Structure-Activity Relationship; Tuberculosis

2007
Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Bacterial Proteins; Cell-Free System; Fatty Acid Synthases; Humans; Inhibitory Concentration 50; Kinetics; Mass Spectrometry; Molecular Structure; Mycobacterium tuberculosis; NADP; Oxidation-Reduction; Pyrazinamide; Reproducibility of Results; Substrate Specificity

2007
Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12

    Topics: Antitubercular Agents; beta-Alanine; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Niacinamide; Pantetheine; Pantothenic Acid; Pyrazinamide

2014